期刊文献+

血尿酸与冠脉病变的相关性分析 被引量:3

Analysis on the Correlation between Serum Uric Acid Level and Coronary Artery Disease
在线阅读 下载PDF
导出
摘要 目的:探讨冠状动脉造影患者血清尿酸(SUA)水平与冠状动脉病变程度的关系。方法:266例患者根据冠脉造影结果分为对照组(n=79)和冠心病组(n=187),根据冠脉病变支数分为单支病变组、双支病变组和三支病变组。测定各组血清尿酸水平,比较各组患者的血清尿酸水平和血清尿酸与冠脉病变范围的相关性,并分析血UA与冠心病发生之间的关系。结果:UA在冠心病组(399.06±96.32)μmoL/L明显高于对照组(308.45±72.85)μmoL/L,差异有统计学意义(P<0.01)。单支病变组、双支病变组、三支病变组尿酸分别为(386.23±87.04)μmoL/L、(397.76±95.30)μmoL/L、(416.06±80.72)μmoL/L,血尿酸水平呈递增趋势,但三组之间比较差异无统计学意义(P>0.05)。结论:血尿酸水平与冠状动脉病变程度呈正相关。 Objective:To evaluate the relationship between the serum uric acid(SUA) level and the severity of angiographic coronary artery disease(CAD).Method:We divided 266 patients who underwent coronary angiography into control group(n=79)and coronary atherosclerotic heart disease(CHD) group(n=187) in which patients were,in turn,divided into single-,double-and triple-vessel disease groups according to the number of vessels with significant stenosis.The serum uric acid level was determined,and the serum uric acid levels of different groups and the association between the serum uric acid level and coronary lesions were compared,and investigated the association between serum UA and the presence of CHD.Result:Serum UA level in CHD group,(399.06±96.32),μmoL/L was significantly higher than that in control group(308.45±72.85) μmoL/L,respectively and the serum uric acid levels between the two groups were significantly different(P〈0.01).The serum uric acid levels of the single-vessel group,double-vessel group and triple-vessel group were(386.23±87.04)μmoL/L,(397.76±95.30)μmoL/L,(416.06±80.72)μmoL/L,There was a trend of increase of UA level in the three groups,but respectively and the serum uric acid levels in the three groups were no significantly different(P〉0.05).Conclusion:The level of the UA is positively associated with the severity coronary artery lesion.
作者 李文
出处 《河北医学》 CAS 2011年第5期614-617,共4页 Hebei Medicine
关键词 血尿酸 冠脉造影 冠心病 Serum uric acid; Coronary angiography; Coronary heart disease;
  • 相关文献

参考文献11

  • 1Puddu PE,Lanti M,Menotti A,et al.Serum uric for 8hort-term prediction of cardiovascular disease incidence in the Gubbio population study[J].Acta Cardiol,2001,56(4):243-251.
  • 2B ickel C,R upprecht HJ,B Lanferg S Serum acid as an independent predictor of mortality in patients with angiographically provencoronary artery disease[J].Am Cardiol,2002,89(1):12.
  • 3叶任高.内科学[M].第5版北京:人民卫生出版社,2001.877.
  • 4Freedman DS,Williamson DF,Gentr EW,et al.Relation of serum acid to mortality and ischemic heart disease.The Nhannesi Eoidemiologic Follow-up study[J].Am Epidemiol,1995,141(7):637-644.
  • 5Bickel C.Rupprecht HJ,Blankenberg S,et a1.Serum uric acid as an independent predictor of mortality in patients with angiographicaUy proven coronary artery disease[J].AM Cardiol,2002,89(1):12.
  • 6Anker SD,Doehner W,Rauchhaus M,et a1.Uric acid and survial in chronic heart failure:validation and application in metabolic,functional,and hemodynamic staging[J].Circulation,2003,107(15):1991.
  • 7Hare JM,Johnson RJ.Uric acid predicts clinical outcomes in heart failure:insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology[J].Circulation,2003,107(15):1951.
  • 8杨胜利.急性冠脉综合征触发的病理生理机制[J].中国血液流变学杂志,2003,13(1):88-92. 被引量:36
  • 9Steinberg HO,Brechtel G,Johnson A,et al.Insulin mediated akeletal muscle vasodilatation isnitril oxide dependent[J].Clin Invest,1994,94:1172.
  • 10Andrew J,Maxwell.Uric acid is closely linked to vascular nitric oxide activity[J].Am Coll Cardiol,2001,38:1850-1858.

二级参考文献36

  • 1张海峰,王雪薇.血尿酸与冠心病的相关性[J].中国急救复苏与灾害医学杂志,2007,2(1):17-19. 被引量:2
  • 2李婧,李莉,陈文强,葛云玲,周其华,宗春饶.尿酸与冠心病病变程度的相关性[J].中国误诊学杂志,2004,4(11):1851-1851. 被引量:7
  • 3薛丽,张爱伦.血尿酸与冠心病的关系及其机制的研究进展[J].心血管病学进展,2006,27(1):50-52. 被引量:14
  • 4O' Mallty T, Ludlam CA, Riemerrnsa RA, et al. Early increase in levels of soluble inter-cellalar adhesion molecule-l(sICAM-1) ;potential risk factor for the acute coronary syndromes [ J ]. Eur Heart J, 2001,22 (14) :1226-1234.
  • 5de-Winter R J, Fischer J, Bholasingh R. C-reactive protein and cardiac troponin T in risk stratification: diferences in optimal timing oftests early after the onset of chest pain[J]. Clin Chem,2000,46(10) : 1597-- 1603.
  • 6de-Winter R J, Fischer JC, de-Jongh T, et al. Different time frames for the occmrence of elevated levels of cardiac troponin T and C-reactive protein in patients with acute myocardial infarction [J]. Clin Chern Lab Med,2000,38(11) : 1151-- 1153.
  • 7Chandra HR, Choudhaty N, O' Neill C, et al. Chlamydia pneumoniae exposure and inflammatory markers in acute coronary syndrome(CIMACS) [ J ]. Am J Cardiol, 2001,88(3) :214--218.
  • 8Deckers JW. Smoking and survival in acute coronary syndrome: the fog is clearing[J]. Eur Heart J ,2001,22(9):.724-726.
  • 9Thompson PL. Clinical relevance of statins: instituting treatment early in acute coronary syndrome patients[ J ]. At hero.let Suppl, 2001,2 ( 1 ) : 15-- 19.
  • 10Schwartz CG, Olssoo AG, Ezekowitz MD, et al. Effects of atorvas tatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial[J]. JAMA, 2001,2S5(13) : 1711-1718.

共引文献39

同被引文献26

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部